Page last updated: 2024-10-24

chloroquine and Respiratory Syncytial Virus Infections

chloroquine has been researched along with Respiratory Syncytial Virus Infections in 1 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Respiratory Syncytial Virus Infections: Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Rahman, F1
Libre, C1
Oleinikov, A1
Tcherniuk, S1

Other Studies

1 other study available for chloroquine and Respiratory Syncytial Virus Infections

ArticleYear
Chloroquine and pyrimethamine inhibit the replication of human respiratory syncytial virus A.
    The Journal of general virology, 2021, Volume: 102, Issue:8

    Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Chloroquine; Disease Models, Animal; Female; Hu

2021